Hydrofarm Holdings Group Announces Fourth Quarter and Full Year 2025 Results
Rhea-AI Summary
Hydrofarm (Nasdaq: HYFM) reported Q4 and full-year 2025 results on March 27, 2026. Q4 net sales fell 32.7% to $25.1 million; gross profit margin rose to 8.5% and adjusted gross margin to 15.4%. The company recorded a $232.2 million impairment, driving a Q4 net loss of $242.2 million. Cash was $6.3 million at year-end and Adjusted EBITDA improved to $(4.9) million. Hydrofarm has substantially completed U.S. manufacturing consolidation, reduced U.S. distribution centers, deferred a Term Loan interest payment (event of default), and terminated its Revolving Credit Facility while pursuing strategic alternatives.
Positive
- Adjusted Gross Profit Margin improved to 15.4% of net sales
- Adjusted EBITDA improved to $(4.9) million
- Adjusted SG&A reduced by 18.9% year-over-year
- Completed U.S. manufacturing consolidation and fewer distribution centers
Negative
- Q4 net sales declined 32.7% to $25.1 million
- Q4 net loss of $242.2 million including a $232.2 million impairment
- Year-end cash of only $6.3 million
- Term Loan event of default after deferred interest and reclassification to current debt
- Revolving Credit Facility was terminated on February 17, 2026
News Market Reaction – HYFM
In the Mar 27 session, HYFM declined 4.43%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Nov 12 | Q3 2025 earnings | Negative | -16.1% | Q3 2025 sales and margins declined with continued net losses and restructuring. |
| Aug 12 | Q2 2025 earnings | Negative | -2.9% | Q2 2025 showed large sales drop despite cost savings and positive free cash flow. |
| May 13 | Q1 2025 earnings | Negative | -13.1% | Q1 2025 net sales declined and net loss widened amid industry headwinds. |
| Mar 05 | FY 2024 earnings | Negative | -20.9% | Q4 and 2024 results showed revenue declines and larger full-year net loss. |
| Nov 07 | Q3 2024 earnings | Negative | -1.2% | Q3 2024 sales fell despite better margins and reaffirmed outlook. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings releases have consistently led to negative reactions, with an average move of -10.84% and all recent earnings events trading lower afterward.
Over the past year, Hydrofarm’s earnings updates have highlighted persistent net sales declines, widening or sizable net losses, and ongoing restructuring to cut SG&A and improve margins. Events on Mar 5, 2025, May 13, 2025, Aug 12, 2025, and Nov 12, 2025 all showed revenue pressure despite margin and cost actions, with shares falling after each release. Today’s Q4 and full-year 2025 results continue that pattern of challenging fundamentals paired with restructuring efforts.
Key Terms
adjusted gross profit margin financial
adjusted sg&a financial
adjusted ebita financial
free cash flow financial
non-gaap measures financial
impairment charge financial
term loan financial
event of default regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
SHOEMAKERSVILLE, Pa., March 27, 2026 (GLOBE NEWSWIRE) -- Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, today announced financial results for its fourth quarter and fiscal year ended December 31, 2025.
Fourth Quarter vs. Prior Year Period:
- Net sales decreased to
$25.1 million compared to$37.3 million . - Gross Profit Margin increased to
8.5% of net sales compared to4.9% . - Adjusted Gross Profit Margin(1) increased to
15.4% of net sales compared to9.6% . - SG&A expense and Adjusted SG&A(1) expense decreased by
43.5% and18.9% , respectively. - Net loss increased to
$242.2 million compared to$17.5 million . Net loss in the fourth quarter of 2025 included a non-cash impairment charge of$232.2 million , primarily attributable to intangible assets. - Adjusted EBITDA(1) of
$(4.9) million compared to$(7.3) million . - Cash used in operating activities and Free Cash Flow(1) were
$(4.0) million and$(4.3) million , respectively.
(1) Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted SG&A, Adjusted SG&A as a percent of net sales, Adjusted EBITDA, and Free Cash Flow are non-GAAP measures. For a description of our non-GAAP measures see the “Non-GAAP Measures” section accompanying this release; and for reconciliations of GAAP to non-GAAP measures see the “Reconciliation of Non-GAAP Measures” accompanying this release.
Bill Toler, Chief Executive Officer of Hydrofarm, said, "In the fourth quarter we continued to execute against our strategy and achieved our best proprietary sales mix quarter of 2025. Despite this sales mix improvement, lower volumes hindered our Adjusted Gross Profit Margin in the quarter. We reduced Adjusted SG&A expense by
Fourth Quarter 2025 Financial Results
Net sales in the fourth quarter of 2025 decreased
Gross Profit increased to
Selling, general and administrative (“SG&A”) expense was
Net loss was
Adjusted EBITDA(1) increased to
Balance Sheet, Liquidity and Cash Flow
As of December 31, 2025, the Company had
Cash used in operating activities was
On February 4, 2026, the Company elected to defer making the interest payment of approximately
Strategic Priorities
Hydrofarm remains committed to its strategic priorities: drive high-quality revenue streams, improve profit margins and strengthen financial position. While maintaining our dedication to customer service, we are focused on reducing costs and improving productivity within the organization. Our initiatives include implementing operational changes, consolidating our facility footprint, reducing headcount, and focusing our sales efforts on our proprietary brand offerings.
(1) Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted SG&A, Adjusted SG&A as a percent of net sales, Adjusted EBITDA, and Free Cash Flow are non-GAAP measures. For a description of our non-GAAP measures see the “Non-GAAP Measures” section accompanying this release; and for reconciliations of GAAP to non-GAAP measures see the “Reconciliation of Non-GAAP Measures” accompanying this release.
About Hydrofarm Holdings Group, Inc.
Hydrofarm is a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, including grow lights, climate control solutions, grow media and nutrients, as well as a broad portfolio of innovative proprietary branded products. For over 40 years, Hydrofarm has helped growers make growing easier and more productive. The Company’s mission is to empower growers, farmers and cultivators with products that enable greater quality, efficiency, consistency and speed in their grow projects.
Cautionary Note Regarding Forward-Looking Statements
Statements contained in this press release, other than statements of historical fact, which address activities, events and developments that the Company expects or anticipates will or may occur in the future, including, but not limited to, information regarding the future economic performance and financial condition of the Company, the plans and objectives of the Company’s management, and the Company’s assumptions regarding such performance and plans are “forward-looking statements” within the meaning of the U.S. federal securities laws that are subject to risks and uncertainties. These forward-looking statements generally can be identified as statements that include phrases such as “guidance,” “outlook,” “projected,” “believe,” “target,” “predict,” “estimate,” “forecast,” “strategy,” “may,” “goal,” “expect,” “anticipate,” “intend,” “plan,” “foresee,” “likely,” “will,” “should” or other similar words or phrases. Actual results could differ materially from the forward-looking information in this release due to a variety of factors, including, but not limited to:
The Company's ability to continue as a going concern; The Company's level of indebtedness; The market in which the Company operates has been substantially adversely impacted by conditions of the agricultural and cannabis industries, including oversupply and decreasing prices of the products the Company's end customers sell, which, in turn, has materially adversely impacted the Company's sales and other results of operations and which may continue to do so in the future; If industry conditions worsen or are sustained for a lengthy period, the Company could be forced to take additional impairment charges and/or inventory and accounts receivable reserves, which could be substantial, and, ultimately, the Company may face liquidity challenges; The Company’s current and future debt facilities may limit the operation of the Company’s business including restricting its ability to sell products directly to the cannabis industry; Although equity financing may be available, the Company's current stock prices are at depressed levels and any such financing would be dilutive; Interruptions in the Company's supply chain could adversely impact expected sales growth and operations; Increased prices and inflation could adversely impact the Company's performance and financial results; Global political and economic conditions including the imposition of potential tariffs could increase the costs of the Company's products and adversely impact the competitiveness of the Company's products and the Company's financial results; The Company may be unable to meet the continued listing standards of Nasdaq; The Company's restructuring activities may increase our expenses and cash expenditures, and may not have the intended cost saving effects; The highly competitive nature of the Company’s markets could adversely affect its ability to maintain or grow revenues; Certain of the Company’s products may be purchased for use in new or emerging industries or segments, including the cannabis industry, and/or be subject to varying, inconsistent, and rapidly changing laws, regulations, administrative and enforcement approaches, and consumer perceptions which may adversely impact the market for the Company’s products; The market for the Company’s products has been impacted by conditions impacting its customers, including related crop prices, climate change, and other factors impacting growers; Compliance with government laws and regulations including environmental and other public health regulations or changes in such regulations or regulatory enforcement priorities could increase the Company’s costs of doing business or limit the Company’s ability to market all of its products; Damage to the Company’s reputation or the reputation of its products or products it markets on behalf of third parties could have an adverse effect on its business; If the Company is unable to effectively execute its e-commerce business, its reputation and operating results may be harmed; The Company’s operations may be impaired if its information technology systems fail to perform adequately or if it is the subject of a data breach or cyber-attack; The Company may not be able to adequately protect its intellectual property and other proprietary rights that are material to the Company’s business; Acquisitions, other strategic alliances and investments could result in operating and integration difficulties, dilution and other harmful consequences that may adversely impact the Company’s business and results of operations. Additional detailed information concerning a number of the important factors that could cause actual results to differ materially from the forward-looking information contained in this release is readily available in the Company’s annual, quarterly and other reports. The Company disclaims any obligation to update developments of these risk factors or to announce publicly any revision to any of the forward-looking statements contained in this release, or to make corrections to reflect future events or developments except as otherwise required by law.
Contact:
ir@hydrofarm.com
| Hydrofarm Holdings Group, Inc. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (In thousands, except share and per share amounts) | ||||||||||||||||
| Three months ended December 31, | Twelve months ended December 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Net sales | $ | 25,123 | $ | 37,314 | $ | 134,252 | $ | 190,288 | ||||||||
| Cost of goods sold | 22,994 | 35,476 | 119,043 | 158,155 | ||||||||||||
| Gross profit | 2,129 | 1,838 | 15,209 | 32,133 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Selling, general and administrative | 9,580 | 16,958 | 59,948 | 72,794 | ||||||||||||
| Impairments | 232,179 | — | 232,179 | — | ||||||||||||
| Loss on asset disposition | — | — | — | 11,520 | ||||||||||||
| Loss from operations | (239,630 | ) | (15,120 | ) | (276,918 | ) | (52,181 | ) | ||||||||
| Interest expense | (3,328 | ) | (3,585 | ) | (13,427 | ) | (15,237 | ) | ||||||||
| Other (expense) income, net | (45 | ) | 1,196 | (185 | ) | 1,570 | ||||||||||
| Loss before tax | (243,003 | ) | (17,509 | ) | (290,530 | ) | (65,848 | ) | ||||||||
| Income tax benefit (expense) | 849 | (4 | ) | 740 | (869 | ) | ||||||||||
| Net loss | $ | (242,154 | ) | $ | (17,513 | ) | $ | (289,790 | ) | $ | (66,717 | ) | ||||
| Net loss per share: | ||||||||||||||||
| Basic | $ | (51.89 | ) | $ | (3.80 | ) | $ | (62.35 | ) | $ | (14.51 | ) | ||||
| Diluted | $ | (51.89 | ) | $ | (3.80 | ) | $ | (62.35 | ) | $ | (14.51 | ) | ||||
| Weighted-average shares of common stock outstanding: | ||||||||||||||||
| Basic | 4,667,004 | 4,607,762 | 4,647,945 | 4,598,640 | ||||||||||||
| Diluted | 4,667,004 | 4,607,762 | 4,647,945 | 4,598,640 | ||||||||||||
| Hydrofarm Holdings Group, Inc. CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (In thousands, except share and per share amounts) | ||||||||
| December 31, | ||||||||
| 2025 | 2024 | |||||||
| Assets | | | ||||||
| Current assets: | | | ||||||
| Cash and cash equivalents | $ | 6,309 | $ | 26,111 | ||||
| Accounts receivable, net | 8,186 | 14,756 | ||||||
| Inventories | 33,324 | 50,633 | ||||||
| Prepaid expenses and other current assets | 3,622 | 3,712 | ||||||
| Total current assets | 51,441 | 95,212 | ||||||
| Property, plant and equipment, net | 30,334 | 37,545 | ||||||
| Operating lease right-of-use assets | 37,765 | 42,869 | ||||||
| Intangible assets, net | 2,801 | 249,002 | ||||||
| Other assets | 1,463 | 1,476 | ||||||
| Total assets | $ | 123,804 | $ | 426,104 | ||||
| Liabilities and stockholders’ (deficit) equity | | | ||||||
| Current liabilities: | | | ||||||
| Accounts payable | $ | 9,752 | $ | 12,279 | ||||
| Accrued expenses and other current liabilities | 7,688 | 10,647 | ||||||
| Deferred revenue | 2,742 | 2,611 | ||||||
| Current portion of operating lease liabilities | 7,543 | 7,731 | ||||||
| Current portion of finance lease liabilities | 455 | 459 | ||||||
| Current portion of long-term debt | 111,853 | 1,260 | ||||||
| Total current liabilities | 140,033 | 34,987 | ||||||
| Long-term operating lease liabilities | 32,800 | 37,553 | ||||||
| Long-term finance lease liabilities | 7,381 | 7,830 | ||||||
| Long-term debt | 50 | 114,693 | ||||||
| Deferred tax liabilities | 2,130 | 3,047 | ||||||
| Other long-term liabilities | 4,706 | 4,272 | ||||||
| Total liabilities | 187,100 | 202,382 | ||||||
| Commitments and contingencies | | | ||||||
| Stockholders’ (deficit) equity | | | ||||||
| Common stock ( | — | — | ||||||
| Additional paid-in capital | 791,227 | 790,094 | ||||||
| Accumulated other comprehensive loss | (7,272 | ) | (8,911 | ) | ||||
| Accumulated deficit | (847,251 | ) | (557,461 | ) | ||||
| Total stockholders’ (deficit) equity | (63,296 | ) | 223,722 | |||||
| Total liabilities and stockholders’ (deficit) equity | $ | 123,804 | $ | 426,104 | ||||
| Hydrofarm Holdings Group, Inc. RECONCILIATION OF NON-GAAP MEASURES (In thousands, except share and per share amounts) (Unaudited) | ||||||||||||||||
| Three months ended December 31, | Twelve months ended December 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Reconciliation of Adjusted Gross Profit: | ||||||||||||||||
| Gross Profit (GAAP) | 2,129 | 1,838 | 15,209 | 32,133 | ||||||||||||
| Depreciation, depletion and amortization | 1,044 | 1,362 | 5,119 | 6,222 | ||||||||||||
| Restructuring expenses1 | 688 | 388 | 5,104 | 1,946 | ||||||||||||
| Severance and other2 | — | 5 | — | 5 | ||||||||||||
| Adjusted Gross Profit (Non-GAAP) | $ | 3,861 | $ | 3,593 | $ | 25,432 | $ | 40,306 | ||||||||
| As a percent of net sales: | ||||||||||||||||
| Gross Profit Margin (GAAP) | 8.5 | % | 4.9 | % | 11.3 | % | 16.9 | % | ||||||||
| Adjusted Gross Profit Margin (Non-GAAP) | 15.4 | % | 9.6 | % | 18.9 | % | 21.2 | % | ||||||||
| Three months ended December 31, | Twelve months ended December 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Reconciliation of Adjusted SG&A: | ||||||||||||||||
| Selling, general and administrative (GAAP) | $ | 9,580 | $ | 16,958 | $ | 59,948 | $ | 72,794 | ||||||||
| Depreciation, depletion and amortization | 41 | 6,005 | 18,023 | 24,469 | ||||||||||||
| Restructuring expenses1 | 333 | 114 | 495 | 277 | ||||||||||||
| Severance and other2 | 100 | (99 | ) | 459 | 165 | |||||||||||
| Stock-based compensation3 | 215 | 93 | 1,186 | 2,399 | ||||||||||||
| Acquisition and integration expenses4 | 99 | — | 324 | — | ||||||||||||
| Adjusted SG&A (Non-GAAP) | $ | 8,792 | $ | 10,845 | $ | 39,461 | $ | 45,484 | ||||||||
| As a percent of net sales: | ||||||||||||||||
| SG&A (GAAP) | 38.1 | % | 45.4 | % | 44.7 | % | 38.3 | % | ||||||||
| Adjusted SG&A (Non-GAAP) | 35.0 | % | 29.1 | % | 29.4 | % | 23.9 | % | ||||||||
| Three months ended December 31, | Twelve months ended December 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Reconciliation of Adjusted EBITDA: | ||||||||||||||||
| Net loss (GAAP) | $ | (242,154 | ) | $ | (17,513 | ) | $ | (289,790 | ) | $ | (66,717 | ) | ||||
| Interest expense | 3,328 | 3,585 | 13,427 | 15,237 | ||||||||||||
| Income tax (benefit) expense | (849 | ) | 4 | (740 | ) | 869 | ||||||||||
| Depreciation, depletion and amortization | 1,085 | 7,367 | 23,142 | 30,691 | ||||||||||||
| Restructuring expenses1 | 1,021 | 502 | 5,599 | 2,223 | ||||||||||||
| Severance and other2 | 100 | (94 | ) | 459 | 170 | |||||||||||
| Stock-based compensation3 | 215 | 93 | 1,186 | 2,399 | ||||||||||||
| Acquisition and integration expenses4 | 99 | — | 324 | — | ||||||||||||
| Other expense (income), net5 | 45 | (1,196 | ) | 185 | (1,570 | ) | ||||||||||
| Impairments6 | 232,179 | — | 232,179 | — | ||||||||||||
| Loss on asset disposition7 | — | — | — | 11,520 | ||||||||||||
| Adjusted EBITDA (Non-GAAP) | $ | (4,931 | ) | $ | (7,252 | ) | $ | (14,029 | ) | $ | (5,178 | ) | ||||
| As a percent of net sales: | ||||||||||||||||
| Net loss (GAAP) | (963.9)% | (46.9)% | (215.9)% | (35.1)% | ||||||||||||
| Adjusted EBITDA (Non-GAAP) | (19.6)% | (19.4)% | (10.4)% | (2.7)% | ||||||||||||
| Three months ended December 31, | Twelve months ended December 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Reconciliation of Free Cash Flow: | ||||||||||||||||
| Net cash (used in) from operating activities (GAAP): | $ | (3,975 | ) | $ | 2,656 | $ | (14,059 | ) | $ | (324 | ) | |||||
| Capital expenditures of Property, plant and equipment (GAAP) | (329 | ) | (270 | ) | (1,024 | ) | (2,892 | ) | ||||||||
| Free Cash Flow (Non-GAAP): | $ | (4,304 | ) | $ | 2,386 | $ | (15,083 | ) | $ | (3,216 | ) | |||||
Notes to GAAP to Non-GAAP reconciliations presented above (Adjusted Gross Profit, Adjusted SG&A, Adjusted EBITDA, and Free Cash Flow):
- For the three and twelve months ended December 31, 2025, and December 31, 2024, Restructuring expenses related primarily to non-cash inventory markdowns, and the cash charges incurred to relocate and terminate certain facilities.
- For the three and twelve months ended December 31, 2025, and December 31, 2024, Severance and other charges primarily related to estimated net legal costs related to certain litigation and severance charges.
- Includes stock-based compensation and related employer payroll taxes on stock-based compensation for the periods presented.
- For the three and twelve months ended December 31, 2025, Acquisition and integration expenses includes consulting, transaction services and legal fees for potential acquisitions, divestitures, or strategic combinations.
- For the twelve months ended December 31, 2025, Other expense, net related primarily to a loss on debt extinguishment recorded in conjunction with the Term Loan prepayment, as well as foreign currency exchange rate gains and losses and other non-operating income and expenses. For the three and twelve months ended December 31, 2024, Other income, net also included a cash settlement arising from an outstanding litigation matter of a previously acquired entity.
- For the three and twelve months ended December 31, 2025, intangible assets and PP&E were impaired as we determined that the fair value was below carrying value, as a result of industry conditions, as well as continued declines in operating cash flows and profitability.
- Loss on asset disposition for the twelve months ended December 31, 2024, relates to the sale in the second quarter of 2024 of the inventories, and property, plant and equipment associated with the Company's Innovative Growers Equipment branded products to CM Fabrication, LLC.
Non-GAAP Financial Measures
We report our financial results in accordance with generally accepted accounting principles in the U.S. (“GAAP”). Management believes that certain non-GAAP financial measures provide investors with additional useful information in evaluating our performance and that excluding certain items that may vary substantially in frequency and magnitude period-to-period from net loss provides useful supplemental measures that assist in evaluating our ability to generate earnings and to more readily compare these metrics between past and future periods. These non-GAAP financial measures may be different than similarly titled measures used by other companies.
To supplement our condensed consolidated financial statements which are prepared in accordance with GAAP, we use "Adjusted EBITDA", "Adjusted Gross Profit", "Adjusted SG&A", "Free Cash Flow", "Net Debt", and "Liquidity" which are non-GAAP financial measures. We also present certain of these non-GAAP metrics as a percentage of net sales. Our non-GAAP financial measures should not be considered in isolation from, or as substitutes for, financial information prepared in accordance with GAAP. There are several limitations related to the use of our non-GAAP financial measures as compared to the closest comparable GAAP measures.
We define Adjusted EBITDA (non-GAAP) as net loss (GAAP) excluding interest expense, income taxes, depreciation, depletion and amortization, stock-based compensation including employer payroll taxes on stock-based compensation, restructuring expenses, impairments, severance, loss on asset disposition, other income/expense, net, and other non-cash, unusual and/or infrequent costs (i.e., acquisition and integration expenses), which we do not consider in our evaluation of ongoing operating performance.
We define Adjusted EBITDA (non-GAAP) as a percent of net sales as Adjusted EBITDA (as defined above) divided by net sales in the respective period.
We define Adjusted Gross Profit (non-GAAP) as Gross Profit (GAAP) excluding depreciation, depletion, and amortization, restructuring expenses, severance and other expenses, and other non-cash, unusual and/or infrequent costs, which we do not consider in our evaluation of ongoing operating performance.
We define Adjusted Gross Profit Margin (non-GAAP) as a percent of net sales as Adjusted Gross Profit (as defined above) divided by net sales in the respective period.
We define Adjusted SG&A (non-GAAP) as SG&A (GAAP) excluding depreciation, depletion, and amortization, stock-based compensation including employer payroll taxes on stock-based compensation, restructuring expenses, severance and other expenses, and other non-cash, unusual and/or infrequent costs (i.e., acquisition and integration expenses), which we do not consider in our evaluation of ongoing operating performance.
We define Adjusted SG&A (non-GAAP) as a percent of net sales as Adjusted SG&A (as defined above) divided by net sales in the respective period.
We define Free Cash Flow (non-GAAP) as Net cash from (used in) operating activities less capital expenditures for property, plant and equipment. We believe this provides additional insight into the Company's ability to generate cash and maintain liquidity. However, Free Cash Flow does not represent funds available for investment or other discretionary uses since it does not deduct cash used to service our debt or other cash flows from financing activities or investing activities.
We define Liquidity as total cash, cash equivalents and restricted cash, if applicable, plus available borrowing capacity on our Revolving Credit Facility.
We define Net Debt as total debt principal outstanding plus finance lease liabilities and other debt, less cash, cash equivalents and restricted cash, if applicable.
